secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001193125-23-068511
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology says SVB exposure immaterial; loan facility with SVB under review
------------------------------------------------------------------------------

- Uninsured cash at SVB is less than 0.8% of total cash equivalents and investments.
- Majority of cash in segregated custody at U.S. Bank via SAM; SVB has no claim.
- Has up to $100M secured term loan; SVB funded 50%; assessing options for SVB's position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/0001193125-23-068511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/d456798d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-068511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer